Abstract: Given longstanding problems with patient engagement across the continuum of care and the need to address growing health disparities, individualized assessments represent an important element in clinical interventions. The present method (and system that executes this method) is a novel procedure that employs idiographic techniques, an n-tier cross-platform architecture, and system features that automatically and quickly generate individualized patient assessment data for use in clinical interventions.
Type:
Grant
Filed:
May 1, 2020
Date of Patent:
September 26, 2023
Assignee:
CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
Abstract: Infectious diseases have been sources of large-scale epidemics and pandemics resulting in millions of casualties worldwide. Detection of these biological agents normally involves several lab processes including sample preparation, nucleic acid separation and amplification, and diagnostic analysis. These steps, either performed manually or automated by high-throughput machinery, are tedious, expensive, and highly susceptible to cross-contamination. The present system is an integrated lab-on-a-device designed, developed, and tested in compatibility with a mechanical fixture for sample-to-answer biological analysis of infectious diseases.
Type:
Grant
Filed:
March 20, 2019
Date of Patent:
July 19, 2022
Assignee:
CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
Inventors:
Benjamin Liu, Eva McGhee, Robin Liu, Miguel Nava
Abstract: A system is disclosed that includes a holder having a pressurized chamber and configured to secure an aerosol delivery device at least partially within the pressurized chamber. A test chamber is connected to the holder, the test chamber having an inlet allowing an aerosol from the aerosol delivery device to enter the test chamber.
Type:
Grant
Filed:
August 2, 2017
Date of Patent:
May 11, 2021
Assignees:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
Abstract: The invention provides methods, compositions, uses of compositions, assays and kits for modulating brown adipose tissue (BAT) in animals and patients with obesity, insulin resistance and perturbed glucose homeostasis are disclosed. Accordingly, methods, compositions, uses of compositions, and kits are useful for the amelioration of pathological conditions characterized by storage of excess energy, insulin resistance and related metabolic syndromes often associated with obesity.
Type:
Grant
Filed:
April 1, 2013
Date of Patent:
June 20, 2017
Assignee:
Charles R. Drew University of Medicine and Science
Abstract: Provided herein are novel nucleic acid sequences, vectors comprising such nucleic acid sequences, host cells comprising such vectors, and transgenic animals comprising such nucleic acid sequences, and related molecules and methods relating thereto. Such novel nucleic acid sequences, vectors comprising such nucleic acid sequences, host cells comprising such vectors, and transgenic animals comprising such nucleic acid sequences, and related molecules and methods provide conditional overexpression of genes, such as myostatin, and transgenic animals conditionally overexpression genes, such as myostatin.
Type:
Grant
Filed:
July 6, 2012
Date of Patent:
July 21, 2015
Assignee:
CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE